TOGETHER trial shows positive effect for ivermectin
The TOGETHER trial was widely reported as showing that ivermectin was not effective in covid-19, but a straightforward analysis of the results reveals a 59 per cent reduction… read more.
The latest coronavirus developments and scientific research on prevention and treatment.
The TOGETHER trial was widely reported as showing that ivermectin was not effective in covid-19, but a straightforward analysis of the results reveals a 59 per cent reduction… read more.
The best time to administer ivermectin is at the beginning of a covid-19 infection so that virus is killed and disease progression averted, according to Colleen Aldous, Professor… read more.
Professor Colleen Aldous is a research professor at the School of Clinical Medicine at the University of Kwazulu-Natal in South Africa. She recently described the SAIVE trial of… read more.
For frontline healthcare workers, the mental health impact from the pandemic is extending beyond career burnout. Much of the attention on the mental toll suffered by frontline workers… read more.
Nearly half a million people missed out on starting medication to lower their blood pressure during the Covid-19 pandemic, according to research supported by the British Heart Foundation… read more.
Most symptoms or conditions that develop after mild covid-19 infection linger for several months but return to normal within a year, finds a large study from Israel published… read more.
Global willingness to accept a COVID-19 vaccine increased from 75.2% in 2021 to 79.1% in 2022, according to a new survey of 23 countries that represent more than 60% of… read more.
Patients in the hospital with Covid-19 related breathing difficulty require intubation less often if they lie face down in a prone position. Researchers reported this finding on Dec…. read more.
A recent study provides preliminary evidence of the long-term relationship between prevention and control measures and influenza transmission in China during the COVID-19 pandemic, accounting for the impact… read more.
Molnupiravir (taken as an 800mg dose twice daily for five days) does not reduce hospital admissions or deaths in vaccinated adults with COVID-19 infection who are at higher… read more.
Smell loss is one of the most prevalent symptoms of long Covid according to a new study from the University of East Anglia. New research published today reveals… read more.
According to a new study published in Nursing Outlook, the journal of the American Academy of Nursing, chronic hospital nurse understaffing and poor hospital work environments that predated the Covid-19 pandemic… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.